Songtao Li Selected Research

Muscular Diseases (Myopathy)

1/2020	Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease.
11/2015	Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Songtao Li Research Topics

Disease

19	Glycogen Storage Disease Type II (Pompe's Disease) 01/2022 - 08/2008
14	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2014
12	Inflammation (Inflammations) 03/2024 - 08/2014
11	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2023 - 11/2012
10	Neoplasms (Cancer) 04/2024 - 01/2019
6	Hepatorenal form of glycogen storage disease 12/2019 - 04/2008
5	Fatty Liver 04/2024 - 04/2014
5	Liver Diseases (Liver Disease) 03/2024 - 01/2019
5	Obesity 03/2022 - 03/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2009
4	Weight Gain 04/2024 - 11/2015
4	Insulin Resistance 01/2022 - 02/2013
3	Atherosclerosis 05/2023 - 01/2017
3	Body Weight (Weight, Body) 01/2021 - 08/2014
3	Hypoglycemia (Reactive Hypoglycemia) 04/2016 - 08/2009
2	Metabolic Diseases (Metabolic Disease) 12/2023 - 01/2021
2	Liver Neoplasms (Liver Cancer) 10/2023 - 10/2019
2	Bone Resorption 09/2023 - 01/2021
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2023 - 01/2021
2	Necrosis 02/2023 - 01/2022
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 12/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2022
2	Muscle Weakness 01/2022 - 02/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2016
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 11/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020 - 01/2012
2	Muscular Diseases (Myopathy) 01/2020 - 11/2015
2	Hypertrophy 01/2020 - 05/2016
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 01/2016
2	Cognitive Dysfunction 01/2015 - 01/2015
2	Dyslipidemias (Dyslipidemia) 11/2013 - 01/2012
2	Hyperlipidemias (Hyperlipidemia) 09/2013 - 02/2013
1	Cough 04/2024
1	Constipation 12/2023
1	Intraoperative Complications 12/2023

Drug/Important Bio-Agent (IBA)

16	AcidsIBA 01/2022 - 08/2008
15	GlucosidasesIBA 01/2022 - 11/2010
8	EnzymesIBA 03/2024 - 11/2010
8	LipidsIBA 12/2023 - 11/2013
6	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 11/2015
6	GlycogenIBA 01/2022 - 08/2008
6	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 04/2008
5	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 12/2019 - 04/2008
5	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 01/2019 - 11/2010
5	human GAA protein (Myozyme)FDA Link 05/2016 - 02/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2014
4	ClenbuterolIBA 05/2016 - 06/2011
3	Therapeutic UsesIBA 09/2023 - 01/2014
3	salvianolic acid AIBA 05/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 08/2013
3	Interleukin-6 (Interleukin 6)IBA 02/2023 - 01/2022
3	Acetylcysteine (Siran)FDA LinkGeneric 06/2022 - 04/2014
3	CationsIBA 01/2019 - 01/2013
3	Insulin (Novolin)FDA Link 04/2016 - 11/2015
3	Triglycerides (Triacylglycerol)IBA 08/2015 - 09/2013
3	Nonesterified Fatty Acids (NEFA)IBA 08/2015 - 01/2012
2	Peptides (Polypeptides)IBA 04/2024 - 01/2019
2	LigandsIBA 04/2024 - 01/2021
2	SterolsIBA 04/2024 - 02/2013
2	Dietary Fats (Dietary Fat)IBA 12/2023 - 01/2022
2	AntioxidantsIBA 09/2023 - 03/2022
2	Long Noncoding RNAIBA 05/2023 - 06/2022
2	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2020
2	GenisteinIBA 02/2023 - 03/2010
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2023 - 08/2021
2	ORALIT (ORS)IBA 01/2023 - 01/2015
2	Retinaldehyde (Retinal)IBA 08/2022 - 12/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022 - 12/2020
2	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2017
2	Messenger RNA (mRNA)IBA 06/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 08/2021 - 02/2009
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2019
2	IronIBA 01/2021 - 02/2009
2	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 02/2016
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 05/2016
2	Sirtuin 3IBA 01/2019 - 01/2017
2	PalmitatesIBA 04/2017 - 11/2015
2	CholesterolIBA 04/2016 - 11/2013
2	stearic acid (magnesium stearate)FDA LinkGeneric 01/2016 - 02/2013
2	AntibodiesIBA 01/2015 - 02/2010
2	TeaIBA 01/2015 - 01/2015
2	AdiponectinIBA 08/2013 - 01/2013
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2013 - 11/2012
1	Prednisone (Sone)FDA LinkGeneric 04/2024
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024
1	JNK Mitogen-Activated Protein KinasesIBA 03/2024
1	MAP Kinase Kinase Kinase 5IBA 03/2024
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2024
1	Claudin-1IBA 12/2023
1	Loperamide (Imodium)FDA LinkGeneric 12/2023
1	OccludinIBA 12/2023
1	CarbohydratesIBA 12/2023

Therapy/Procedure

18	Therapeutics 12/2023 - 11/2010
8	Enzyme Replacement Therapy 01/2020 - 02/2010
3	Lasers (Laser) 12/2023 - 10/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2023 - 06/2020
2	Injections 05/2023 - 02/2012
1	Oral Administration 04/2024